The latest announcement is out from Oramed Pharmaceuticals (ORMP).
Oramed Pharmaceuticals Inc. has announced the appointment of Mr. Yehuda Reznick as a new board member and chair of the audit committee, effective from April 1, 2024. Reznick, a seasoned professional with extensive experience in auditing and taxation, previously partnered with Kesselman & Kesselman CPA and Shachak, Peer Reznick CPA. His expertise is further acknowledged as he is designated the financial expert of the audit committee. Reznick’s association with other companies and his expected compensation align with the standard for non-executive directors at Oramed.
See more data about ORMP stock on TipRanks’ Stock Analysis page.
